Schroder Investment Management Group
IOVA icon

Schroder Investment Management Group’s Iovance Biotherapeutics IOVA Stock Holding History

Schroder Investment Management Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-897,354
Closed -$1.54M – 1222
2025
Q2 		$1.54M Buy
897,354
+394,791
+79% +$982K ﹤0.01% 944
2025
Q1 		$1.79M Buy
502,563
+259,267
+107% +$1.34M ﹤0.01% 922
2024
Q4 		$1.74M Hold
243,296
– – ﹤0.01% 943
2024
Q3 		$2.34M Sell
243,296
-525,864
-68% -$4.98M ﹤0.01% 916
2024
Q2 		$6.17M Buy
769,160
+438,377
+133% +$4.7M 0.01% 735
2024
Q1 		$4.9M Buy
330,783
+6,047
+2% +$70.4K 0.01% 784
2023
Q4 		$2.64M Buy
+324,736
New +$1.7M ﹤0.01% 868

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return